Technical Analysis for KPTI - Karyopharm Therapeutics Inc.

Grade Last Price % Change Price Change
grade D 5.72 9.37% 0.49
KPTI closed up 1.75 percent on Tuesday, May 21, 2019, on 1.96 times normal volume. The price action carved out a bearish shooting star candlestick pattern. That may indicate a downside reversal. Look for price to trade beneath the low of the shooting star for confirmation.
3 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Up Up
See historical KPTI trend table...

Date Alert Name Type % Chg
Shooting Star Candlestick Bearish 9.37%
Pocket Pivot Bullish Swing Setup 9.37%
Calm After Storm Range Contraction 9.37%
Doji - Bearish? Reversal 9.37%
BB Squeeze Ended Range Expansion 9.37%
Above Upper BB Strength 9.37%
Upper Bollinger Band Touch Strength 9.37%
Crossed Above 20 DMA Bullish 11.28%
Crossed Above 50 DMA Bullish 11.28%
Expansion Pivot Buy Setup Bullish Swing Setup 11.28%

Older signals for KPTI ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Analyze My Stocks!
Configure default chart indicators
Basic chart:
Profile
Karyopharm Therapeutics Inc., a clinical-stage pharmaceutical company, focuses on the discovery and development of drugs directed against nuclear transport targets for the treatment of cancer and other major diseases. The company's lead drug candidate includes Selinexor, an oral selective inhibitors of nuclear export (SINE) compound that specifically blocks XPO1 cargo binding is in Phase I clinical trials in patients with heavily pretreated relapsed and/or refractory hematological and solid tumor malignancies. Its other drug candidates comprise KPT-350 and related SINE compounds; PAK4 inhibitors; and Verdinexor, a SINE compound that is in Phase IIb clinical trials in pet dogs with newly-diagnosed or first relapse after chemotherapy lymphomas. The company was founded in 2008 and is based in Natick, Massachusetts.
Medicine Cancer Pharmaceutical Diseases Treatment Of Cancer Oncology Chemotherapy Occupational Safety And Health Antibody Drug Conjugates Pixantrone
Is KPTI a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
May 17 Karyopharm Therapeutics Inc. (KTPI) Q1 2019 Earnings Call Transcript
May 16 Karyopharm Announces Results of Clinical Studies Investigating Selinexor to be Presented at the European Hematology Association 2019 Annual Meeting
May 15 Karyopharm’s Founder Sharon Shacham, PhD, Receives NYIPLA Inventor of the Year Award
May 9 Karyopharm Therapeutics Inc. (KPTI) CEO Dr. Michael Kauffman on Q1 2019 Results - Earnings Call Transcript
May 9 Edited Transcript of KPTI earnings conference call or presentation 9-May-19 12:30pm GMT
May 9 Here’s What Hedge Funds Think About Karyopharm Therapeutics Inc (KPTI)
May 9 Karyopharm Therapeutics (KPTI) Reports Q1 Loss, Misses Revenue Estimates
May 9 Karyopharm Therapeutics: 1Q Earnings Snapshot
May 9 Karyopharm Therapeutics misses by $0.23, misses on revenue
May 8 Karyopharm to Participate in Upcoming Investor Conferences
See more KPTI news...
Indicators
Indicator Value
52 Week High 21.71
52 Week Low 3.92
Average Volume 1,032,544
200-Day Moving Average 10.4039
50-Day Moving Average 5.0574
20-Day Moving Average 4.772
10-Day Moving Average 4.742
Average True Range 0.3477
ADX 21.64
+DI 28.5981
-DI 16.1888
Chandelier Exit (Long, 3 ATRs ) 4.6569
Chandelier Exit (Short, 3 ATRs ) 5.3031
Upper Bollinger Band 5.1454
Lower Bollinger Band 4.3986
Percent B (%b) 1.11
BandWidth 15.649623
MACD Line -0.062
MACD Signal Line -0.1434
MACD Histogram 0.0814
Fundamentals Value
Market Cap 246.53 Million
Num Shares 47.1 Million
EPS -2.69
Price-to-Earnings (P/E) Ratio -1.94
Price-to-Sales 2836.82
Price-to-Book 2.82
PEG Ratio -0.13
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 6.18
Resistance 3 (R3) 6.23 5.96 6.02
Resistance 2 (R2) 5.96 5.72 5.94 5.96
Resistance 1 (R1) 5.60 5.57 5.78 5.55 5.91
Pivot Point 5.33 5.33 5.43 5.31 5.33
Support 1 (S1) 4.97 5.09 5.15 4.92 4.55
Support 2 (S2) 4.70 4.94 4.68 4.50
Support 3 (S3) 4.34 4.70 4.44
Support 4 (S4) 4.29